Trametinib, sold under the brand name Mekinist among others, is an anticancer medication used for the treatment of melanoma and glioma. It is a MEK inhibitor...
15 KB (976 words) - 17:10, 20 October 2024
rash, joint pain, fever and tiredness. When taken in combination with trametinib, the most common side effects include fever, tiredness, nausea, chills...
16 KB (1,122 words) - 03:21, 24 April 2024
BRAF inhibitors, such as vemurafenib and dabrafenib and a MEK inhibitor trametinib are the most effective, approved treatments for BRAF positive melanoma...
156 KB (16,312 words) - 20:10, 3 January 2025
BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib. Important prognosis factors for nodular melanoma include: Thickness Ulceration...
4 KB (386 words) - 15:36, 21 May 2024
of NSCLC) can be treated by dabrafenib combined with the MEK inhibitor trametinib; those with activated ROS1 (around 1% of NSCLC) can be inhibited by crizotinib...
90 KB (9,784 words) - 12:48, 29 November 2024
evaluated as a combination treatment against solid tumors together with trametinib in a clinical trial sponsored by the National Cancer Institute. In this...
13 KB (1,295 words) - 07:06, 24 November 2024
metastatic melanoma that harbors BRAF V600E mutation MEK inhibitors (trametinib, MEK162) are used in experiments, often in combination with BRAF inhibitors...
20 KB (2,234 words) - 01:21, 22 July 2024
BRAF inhibitors, such as vemurafenib and dabrafenib; or a MEK inhibitor trametinib may be used. When arising in the nailbed of a digit, the evidence suggests...
24 KB (2,383 words) - 15:31, 14 November 2024
thyroid cancer harboring such mutations. The combination of dabrafenib and trametinib has shown significant increases in overall survival and has been approved...
20 KB (2,157 words) - 22:06, 3 January 2025
Rosuvastatin Crestor 1.37 in hemodialysis patients Lisinopril Prinivil and others 1.38 Ivacaftor Kalydeco 2.2–2.9 Trametinib Mekinist 6.0 at 2 mg once daily...
4 KB (432 words) - 05:16, 4 July 2024
for medical use in the United States in September 2020. Dabrafenib and trametinib have been approved as tissue-agnostic drugs for solid tumors that are...
7 KB (597 words) - 15:52, 6 August 2024
Fecher, Leslie A.; et al. (2012). "Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial"....
3 KB (296 words) - 17:06, 14 September 2023
Lilly/Boehringer) tralokinumab (INN) tralonide (INN) tramadol (INN) tramazoline (INN) trametinib (USAN, INN) tramiprosate (USAN) Trancopal Trandate trandolapril (INN)...
12 KB (563 words) - 00:00, 1 October 2024
are tyrosine kinase inhibitors that may also cause MG), dabrafenib, and trametinib; 3) antipsychotic drugs, i.e., chlorpromazine, pimozide, thioridazine...
81 KB (8,706 words) - 09:28, 4 January 2025
Ceritinib L01ED03 Alectinib L01ED04 Brigatinib L01ED05 Lorlatinib L01EE01 Trametinib L01EE02 Cobimetinib L01EE03 Binimetinib L01EE04 Selumetinib L01EE05 Mirdametinib...
13 KB (935 words) - 04:36, 23 December 2024
cobimetinib, CI-1040, PD0325901, binimetinib (MEK162), selumetinib, and trametinib (GSK1120212) It has been found that acupoint-moxibustion has a role in...
24 KB (3,068 words) - 07:21, 7 June 2024
trial results compared vemurafenib with the combination of dabrafenib and trametinib for metastatic melanoma. Vemurafenib was approved in the United States...
21 KB (1,815 words) - 16:50, 24 November 2024
include uveal melanoma (failed), and differentiated thyroid carcinoma. Trametinib (GSK1120212), FDA-approved to treat BRAF-mutated melanoma. Also studied...
6 KB (719 words) - 23:12, 12 May 2024
including Octreotide, Sirolimus, Anti-plasmin and, at least in one case, Trametinib. Dog breeds commonly affected by lymphangiectasia and/or protein-losing...
10 KB (1,002 words) - 06:53, 6 January 2024
Pacritinib Ruxolitinib MAP2K (MEK) Binimetinib Cobimetinib Selumetinib Trametinib EML4-ALK Crizotinib Entrectinib Lorlatinib Bruton's (BTK) Acalabrutinib...
12 KB (821 words) - 06:14, 23 December 2024
BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib. In February 2024, the Food and Drug Administration approved the first...
58 KB (6,508 words) - 20:52, 6 December 2024
can be tried. Or a BRAF inhibitor can be restarted plus MEK inhibitors trametinib or cobimetinib. Interferon-alpha is an immune system hormone that is very...
53 KB (6,579 words) - 17:52, 2 January 2025
at Moffitt Cancer Center discovered two monotherapy drugs – Mekinist (trametinib) and Tafinlar (dabrafenib) – can be safely combined to overcome or delay...
30 KB (2,979 words) - 06:17, 17 November 2024
including Octreotide, Sirolimus, Anti-plasmin and, at least in one case, Trametinib. The disease was first reported in 1961 by T.A. Waldmann. He described...
8 KB (821 words) - 04:51, 21 November 2024
Drug Evaluation and Research (2023-03-31). "FDA approves dabrafenib with trametinib for pediatric patients with low-grade glioma with a BRAF V600E mutation"...
9 KB (766 words) - 05:02, 14 December 2024
interstellar comet 2I/Borisov. 30 September – By combining doses of lithium, trametinib and rapamycin into a single treatment, researchers extend the lifespan...
257 KB (24,667 words) - 23:33, 29 November 2024
inhibitors, such as vemurafenib and dabrafenib; and an MEK inhibitor trametinib. Melanoma List of cutaneous conditions James, William D.; Berger, Timothy...
5 KB (346 words) - 10:52, 28 March 2024
Novartis Pharmaceuticals melanoma with BRAF V600E or V600K mutations Trametinib Novartis Pharmaceuticals melanoma with BRAF V600E or V600K mutations Dabrafenib...
42 KB (240 words) - 07:06, 3 January 2025
human patients with a kidney disease. By combining doses of lithium, trametinib and rapamycin into a single treatment, researchers extend the lifespan...
203 KB (18,823 words) - 07:55, 26 December 2024
ALK inhibitors with MEK inhibitors: brigatinib+binimetinib, ceritinib+trametinib, and alectinib+cobimetinib. Results for the last two are expected around...
17 KB (1,951 words) - 10:39, 25 January 2024